Roots Analysis is pleased to announce the publication of its recent study, titled, “Microbial Contract Biomanufacturing Market, 2020-2030.

The report features an extensive study of the current market landscape and future opportunities associated with the microbial contract biomanufacturing market. It features a detailed analysis of key drivers and trends related to this evolving domain. In addition to other elements, the study includes:
 A detailed review of the current landscape of companies offering contract manufacturing services.
 Elaborate profiles of key players that specialize in offering services for contract biomanufacturing.
 A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.
 An analysis of the partnerships and expansions that have been established in this domain, in the recent past.
 A competitiveness analysis, highlighting key players engaged in microbial based contract manufacturing, featuring insightful pictorial summaries and representations.
 A detailed proprietary 2×2 representation to assess the current market scenario
 An analysis of the initiatives of big biopharma players engaged in this domain.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
 Type of Product
 API
 FDF

 Type of Biologic
 Proteins
 Enzymes
 Growth Hormones
 Antibody based Drugs
 Others (plasmid DNA, probiotics, microbiome-based biologics)

 Type of Microbial Expression System
 Bacteria
 Yeast
 Others (Algae and fungi)

 Scale of Operation
 Commercial
 Preclinical / Clinical

 Type of End User
 Small Companies
 Mid-sized Companies
 Large / Very Large Companies

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Middle East and North Africa
 Latin America

Transcripts of interviews held with the following senior level representatives of stakeholder companies
 Gaurav Kaushik (Chief Executive Officer and Managing Director, Meteoric Biopharmaceuticals)
 Debbie Pinkston (Vice President, Sales and Business Development, List Biological Laboratories)
 Andrea Conforto (Sales and Marketing, Bioservices Director, Olon)
 Max Rossetto (General Manager, Business Development, Luina Bio)
 Rob van Dijk (Business Development Manager, WACKER Biotech)


Key companies covered in the report
 AGC Biologics
 Aldevron
 BioVectra
 EirGenix
 Etinpro
 Eurogentec
 Northway Biotechpharma
 Ology Bioservices
 Porton Biopharma
 Stelis Biopharma

For additional details, please visit
https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email [email protected]

You may also be interested in the following titles:
1. Drug Repurposing Service Providers Market, 2020 – 2030
2. Antibody Discovery Services and Platforms Market (3rd Edition), 2020-2030
3. Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020 - 2030

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]